{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T05:09:02Z","timestamp":1778303342046,"version":"3.51.4"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,4,28]],"date-time":"2012-04-28T00:00:00Z","timestamp":1335571200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1007\/s00404-012-2340-4","type":"journal-article","created":{"date-parts":[[2012,4,27]],"date-time":"2012-04-27T03:33:02Z","timestamp":1335497582000},"page":"495-503","source":"Crossref","is-referenced-by-count":12,"title":["Use of progestogens in pregnant and infertile patients"],"prefix":"10.1007","volume":"286","author":[{"given":"T\u00fclay","family":"\u00d6zl\u00fc","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ay\u015fenur \u00c7ak\u0131r","family":"G\u00fcng\u00f6r","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melahat Emine","family":"D\u00f6nmez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00fclent","family":"Duran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,4,28]]},"reference":[{"key":"2340_CR1","volume-title":"Williams obstetrics","year":"2010","unstructured":"Cunningham FG (ed) (2010) Williams obstetrics, 23rd edn. McGraw-Hill, New York","edition":"23"},{"key":"2340_CR2","volume-title":"Cleveland clinic current clinical medicine","year":"2009","unstructured":"Carey WD (ed) (2009) Cleveland clinic current clinical medicine, 2nd edn. Saunders, Philadelphia","edition":"2"},{"key":"2340_CR3","volume-title":"Gabbe: obstetrics: normal and problem pregnancies","year":"2007","unstructured":"Gabbe SG (ed) (2007) Gabbe: obstetrics: normal and problem pregnancies, 5th edn. Churchill Livingstone, Philadelphia","edition":"5"},{"key":"2340_CR4","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1097\/01.grf.0000141452.68933.44","volume":"47","author":"PJ Meis","year":"2004","unstructured":"Meis PJ, Connors N (2004) Progesterone treatment to prevent pre-term birth. Clin Obstet Gynecol 47:784\u2013795","journal-title":"Clin Obstet Gynecol"},{"key":"2340_CR5","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0165-0378(83)90237-1","volume":"5","author":"DP Stites","year":"1983","unstructured":"Stites DP, Bugbee S, Siiteri PK (1983) Differential action of progesterone and cortisol on lymphocyte and monocyte interaction during lymphocyte activation\u2014relevance to immunosuppression in pregnancy. J Reprod Immunol 5:215\u2013228","journal-title":"J Reprod Immunol"},{"key":"2340_CR6","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1196\/annals.1335.022","volume":"1034","author":"A Palagiano","year":"2004","unstructured":"Palagiano A, Bulletti C, Pace MC, De Ziegler D, Cicinelli E, Izzo A (2004) Effects of vaginal progesterone on pain and uterine contractility in patients with threatened abortion before twelve weeks of pregnancy. Ann NY Acad Sci 1034:200\u2013210","journal-title":"Ann NY Acad Sci"},{"key":"2340_CR7","unstructured":"Dodd JM, Flenady V, Cincotta R, Crowther CA (2006) Prenatal administration of progesterone for preventing preterm birth. Cochrane Database Syst Rev 25(1):CD004947"},{"key":"2340_CR8","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/j.1471-0528.1999.tb08401.x","volume":"106","author":"S Nielsen","year":"1999","unstructured":"Nielsen S, Hahlin M, Platz-Christensen J (1999) Randomised trial comparing expectant with medical management for first trimester miscarriage. Br J Obstet Gynaecol 106:804\u2013807","journal-title":"Br J Obstet Gynaecol"},{"issue":"11","key":"2340_CR9","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1093\/humrep\/deg475","volume":"18","author":"OS Tang","year":"2003","unstructured":"Tang OS, Chan CC, Ng EH, Lee SW, Ho PC (2003) A prospective, randomized, placebo-controlled trial on the use of mifepristone with sublingual or vaginal misoprostol for medical abortions of less than 9\u00a0weeks gestation. Hum Reprod 18(11):2315\u20132318","journal-title":"Hum Reprod"},{"issue":"6","key":"2340_CR10","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1080\/01443610902980878","volume":"29","author":"P Majhi","year":"2009","unstructured":"Majhi P, Bagga R, Kalra J, Sharma M (2009) Intravaginal use of natural micronised progesterone to prevent pre-term birth: a randomised trial in India. J Obstet Gynaecol 29(6):493","journal-title":"J Obstet Gynaecol"},{"key":"2340_CR11","unstructured":"US Department of Health and Human Services (2011) Food and Drug Administration Statement on Makena.(press release), 30 Mar 2011 US Department of Health and Human Services, Silver Spring"},{"issue":"5","key":"2340_CR12","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jsbmb.2005.08.013","volume":"97","author":"MH Omar","year":"2005","unstructured":"Omar MH, Mashita MK, Lim PS, Jamil MA (2005) Dydrogesterone in threatened abortion: pregnancy outcome. J Steroid Biochem Mol Biol 97(5):421\u2013425 Epub 2005 Nov 15","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"5","key":"2340_CR13","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.jsbmb.2005.08.009","volume":"97","author":"CJ Gruber","year":"2005","unstructured":"Gruber CJ, Huber JC (2005) The role of dydrogesterone in recurrent (habitual) abortion. J Steroid Biochem Mol Biol 97(5):426\u2013430 Epub 2005 Sep 26","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"Suppl 2","key":"2340_CR14","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1046\/j.1365-3016.2001.00004.x","volume":"15","author":"DR Mattison","year":"2001","unstructured":"Mattison DR, Damus K, Fiore E, Petrini J, Alter C (2001) Preterm delivery: a public health perspective. Paediatr Perinat Epidemiol 15(Suppl 2):7\u201316","journal-title":"Paediatr Perinat Epidemiol"},{"issue":"9607","key":"2340_CR15","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0140-6736(08)60108-7","volume":"371","author":"JD Iams","year":"2008","unstructured":"Iams JD, Romero R, Culhane JF, Goldenberg RL (2008) Primary, secondary, and tertiary interventions to reduce the morbidity and mortality of preterm birth. Lancet 371(9607):164","journal-title":"Lancet"},{"issue":"3","key":"2340_CR16","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ajog.2008.12.035","volume":"200","author":"AT Tita","year":"2009","unstructured":"Tita AT, Rouse DJ (2009 Mar) Progesterone for preterm birth prevention: an evolving intervention. Am J Obstet Gynecol 200(3):219\u2013224","journal-title":"Am J Obstet Gynecol"},{"key":"2340_CR17","first-page":"1089","volume":"76","author":"RB Newman","year":"1990","unstructured":"Newman RB, Campbell BA, Stramm SL (1990) Objective tocodynamometry identifies labor onset earlier than subjective maternal perception. Obstet Gynecol 76:1089\u20131092","journal-title":"Obstet Gynecol"},{"key":"2340_CR18","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/0002-9378(85)90141-3","volume":"151","author":"M Yemini","year":"1985","unstructured":"Yemini M, Borestein R, Dreazen E, Apelman Z, Molginer BM, Kessler I et al (1985) Prevention of premature labor by 17 \u03b1-hydroxyprogesterone caproate. Am J Obstet Gynecol 151:574\u2013577","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"2340_CR19","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/AOG.0b013e31817d0262","volume":"112","author":"JM Dodd","year":"2008","unstructured":"Dodd JM, Flenady VJ, Cincotta R, Crowther CA (2008) Progesterone for the prevention of preterm birth: a systematic review. Obstet Gynecol 112(1):127","journal-title":"Obstet Gynecol"},{"issue":"1","key":"2340_CR20","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/AOG.0b013e3181a9454b","volume":"114","author":"TP Waters","year":"2009","unstructured":"Waters TP, Schultz BA, Mercer BM, Catalano PM (2009) Effect of 17alpha-hydroxyprogesterone caproate on glucose intolerance in pregnancy. Obstet Gynecol 114(1):45","journal-title":"Obstet Gynecol"},{"issue":"9","key":"2340_CR21","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.2337\/dc07-0564","volume":"30","author":"A Rebarber","year":"2007","unstructured":"Rebarber A, Istwan NB, Russo-Stieglitz K, Cleary-Goldman J, Rhea DJ, Stanziano GJ et al (2007) Increased incidence of gestational diabetes in women receiving prophylactic 17alpha-hydroxyprogesterone caproate for prevention of recurrent preterm delivery. Diabetes Care 30(9):2277\u20132280 Epub 2007 Jun 11","journal-title":"Diabetes Care"},{"issue":"4","key":"2340_CR22","doi-asserted-by":"crossref","first-page":"392.e1","DOI":"10.1016\/j.ajog.2009.06.036","volume":"201","author":"National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network.","year":"2009","unstructured":"National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network., 4 (2009) The effect of 17-alpha hydroxyprogesterone caproate on the risk of gestational diabetes in singleton or twin pregnancies. Am J Obstet Gynecol 201(4):392.e1","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"2340_CR23","doi-asserted-by":"crossref","first-page":"224.e1","DOI":"10.1016\/j.ajog.2007.01.002","volume":"196","author":"A Rebarber","year":"2007","unstructured":"Rebarber A, Ferrara LA, Hanley ML, Istwan NB, Rhea DJ, Stanziano GJ et al (2007) Increased recurrence of preterm delivery with early cessation of 17-alpha-hydroxyprogesterone caproate. Am J Obstet Gynecol 196(3):224.e1","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"2340_CR24","doi-asserted-by":"crossref","first-page":"54.e1-5","DOI":"10.1016\/j.ajog.2010.08.022","volume":"204","author":"CM Briery","year":"2011","unstructured":"Briery CM, Veillon EW, Klauser CK, Martin RW, Magann EF, Chauhan SP, Morrison JC (2011) Women with preterm premature rupture of the membranes do not benefit from weekly progesterone. Am J Obstet Gynecol 204(1):54.e1-5","journal-title":"Am J Obstet Gynecol"},{"issue":"9680","key":"2340_CR25","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1016\/S0140-6736(09)60947-8","volume":"373","author":"JE Norman","year":"2009","unstructured":"Norman JE, Mackenzie F, Owen P, Mactier H, Hanretty K, Cooper S et al (2009) Progesterone for the prevention of preterm birth in twin pregnancy (STOPPIT): a randomised, double-blind, placebo-controlled study and meta-analysis. Lancet 373(9680):2034","journal-title":"Lancet"},{"issue":"3","key":"2340_CR26","doi-asserted-by":"crossref","first-page":"221.e1","DOI":"10.1016\/j.ajog.2010.12.042","volume":"204","author":"Obstetrix Collaborative Research Network","year":"2011","unstructured":"Obstetrix Collaborative Research Network (2011) 17-hydroxyprogesterone caproate for twin pregnancy: a double-blind, randomized clinical trial. Am J Obstet Gynecol 204(3):221.e1","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"2340_CR27","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/uog.9093","volume":"38","author":"PREDICT Group","year":"2011","unstructured":"PREDICT Group (2011) Prevention of preterm delivery in twin gestations (PREDICT): a multicenter, randomized, placebo-controlled trial on the effect of vaginal micronized progesterone. Ultrasound Obstet Gynecol 38(3):272","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"12","key":"2340_CR28","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.3109\/14767051003702786","volume":"23","author":"National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network","year":"2010","unstructured":"National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network (2010) Second trimester cervical length and risk of preterm birth in women with twin gestations treated with 17-\u03b1hydroxyprogesterone caproate. J Matern Fetal Neonatal Med 23(12):1360","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"3","key":"2340_CR29","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/uog.9092","volume":"38","author":"PREDICT Group","year":"2011","unstructured":"PREDICT Group (2011) Vaginal micronized progesterone and risk of preterm delivery in high-risk twin pregnancies: secondary analysis of a placebo-controlled randomized trial and meta-analysis. Ultrasound Obstet Gynecol 38(3):281","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"2 Pt 1","key":"2340_CR30","first-page":"285","volume":"113","author":"National Institute of Child Health and Human Development (NICHD), Maternal-Fetal Medicine Units Network (MFMU)","year":"2009","unstructured":"National Institute of Child Health and Human Development (NICHD), Maternal-Fetal Medicine Units Network (MFMU) (2009) Prevention of preterm birth in triplets using 17 alpha-hydroxyprogesterone caproate: a randomized controlled trial. Obstet Gynecol 113(2 Pt 1):285","journal-title":"Obstet Gynecol"},{"issue":"3","key":"2340_CR31","doi-asserted-by":"crossref","first-page":"248.e1","DOI":"10.1016\/j.ajog.2010.06.016","volume":"203","author":"Obstetrix Collaborative Research Network","year":"2010","unstructured":"Obstetrix Collaborative Research Network (2010) Failure of 17-hydroxyprogesterone to reduce neonatal morbidity or prolong triplet pregnancy: a double-blind, randomized clinical trial. Am J Obstet Gynecol 203(3):248.e1","journal-title":"Am J Obstet Gynecol"},{"key":"2340_CR32","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1056\/NEJMoa067815","volume":"357","author":"EB Fonseca","year":"2007","unstructured":"Fonseca EB, Celik E, Parra M, Singh M, Nicolaides KH (2007) Progesterone and the risk of preterm birth among women with a short cervix. N Engl J Med 357:462\u2013469","journal-title":"N Engl J Med"},{"key":"2340_CR33","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1136\/bmj.320.7251.1708","volume":"320","author":"AM Nybo Andersen","year":"2000","unstructured":"Nybo Andersen AM, Wohlfahrt J, Christens P, Olsen J, Melbye M (2000) Maternal age and fetal loss: population based register linkage study. Br Med J 320:1708\u20131712","journal-title":"Br Med J"},{"key":"2340_CR34","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1056\/NEJM198807283190401","volume":"319","author":"AJ Wilcox","year":"1988","unstructured":"Wilcox AJ, Weinberg CR, O\u2019Connor JF (1988) Incidence of early loss of pregnancy. N Engl J Med 319:189\u2013194","journal-title":"N Engl J Med"},{"issue":"1","key":"2340_CR35","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1089\/10507250150500676","volume":"11","author":"J Abramson","year":"2001","unstructured":"Abramson J, Stagnaro-Green A (2001) Thyroid antibodies and fetal loss: an evolving story. Thyroid 11(1):57","journal-title":"Thyroid"},{"issue":"5","key":"2340_CR36","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/S0015-0282(02)04207-3","volume":"78","author":"TC Li","year":"2002","unstructured":"Li TC, Iqbal T, Anstie B, Gillham J, Amer S, Wood K et al (2002) An analysis of the pattern of pregnancy loss in women with recurrent miscarriage. Fertil Steril 78(5):1100\u20131106","journal-title":"Fertil Steril"},{"issue":"2","key":"2340_CR37","first-page":"CD003511","volume":"16","author":"DM Haas","year":"2008","unstructured":"Haas DM, Ramsey PS (2008) Progestogen for preventing miscarriage. Cochrane Database Syst Rev 16(2):CD003511","journal-title":"Cochrane Database Syst Rev"},{"key":"2340_CR38","doi-asserted-by":"crossref","first-page":"d1914","DOI":"10.1136\/bmj.d1914","volume":"342","author":"A Coomarasamy","year":"2011","unstructured":"Coomarasamy A, Truchanowicz EG, Rai R (2011) Does first trimester progesterone prophylaxis increase the live birth rate in women with unexplained recurrent miscarriages? BMJ 342:d1914","journal-title":"BMJ"},{"issue":"Suppl 1","key":"2340_CR39","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/humrep\/15.suppl_1.46","volume":"15","author":"BC Choi","year":"2000","unstructured":"Choi BC, Polgar K, Xiao L, Hill JA (2000) Progesterone inhibits in vitro embryotoxic Th1 cytokine production to trophoblast in women with recurrent pregnancy loss. Hum Reprod 15(Suppl 1):46","journal-title":"Hum Reprod"},{"key":"2340_CR40","volume-title":"International statistical classification of diseases and related health problems","author":"World Health Organization","year":"1992","unstructured":"World Health Organization (1992) International statistical classification of diseases and related health problems, vol 1, 10th edn. World Health Organization, Geneva","edition":"10"},{"issue":"3","key":"2340_CR41","first-page":"005943","volume":"16","author":"HA Wahabi","year":"2011","unstructured":"Wahabi HA, Abed Althagafi NF, Elawad M, Al Zeidan RA (2011) Progestogen for treating threatened miscarriage. Cochrane Database Syst Rev 16(3):005943","journal-title":"Cochrane Database Syst Rev"},{"key":"2340_CR42","first-page":"26","volume":"8","author":"I Gerhard","year":"1987","unstructured":"Gerhard I, Gwinner B, Eggert-Kruse W, Runnebaum B (1987) Doubleblind controlled trial of progesterone substitution in threatened abortion. Biol Res Pregnancy Perinatol 8:26\u201334","journal-title":"Biol Res Pregnancy Perinatol"},{"issue":"6","key":"2340_CR43","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1016\/S0022-5347(05)68863-5","volume":"161","author":"RI Silver","year":"1999","unstructured":"Silver RI, Rodriguez R, Chang TS, Gearhart JP (1999) In vitro fertilization is associated with an increased risk of hypospadias. J Urol 161(6):1954\u20131957","journal-title":"J Urol"},{"issue":"4","key":"2340_CR44","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1741-4520.2006.00128.x","volume":"46","author":"I Dudas","year":"2006","unstructured":"Dudas I, Gidai J, Czeizel AE (2006) Population-based case-control teratogenic study of hydroxyprogesterone treatment during pregnancy. Congenit Anom 46(4):194\u2013198","journal-title":"Congenit Anom"},{"issue":"6","key":"2340_CR45","first-page":"775","volume":"65","author":"Z Katz","year":"1985","unstructured":"Katz Z, Lancet M, Skornik J, Chemke J, Mogilner BM, Klinberg M (1985) Teratogenicity of progestogens given during the first trimester of pregnancy. Obstet Gynecol 65(6):775\u2013780","journal-title":"Obstet Gynecol"},{"issue":"Suppl 1","key":"2340_CR46","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.maturitas.2009.11.013","volume":"65","author":"MY El-Zibdeh","year":"2009","unstructured":"El-Zibdeh MY, Yousef LT (2009) Dydrogesterone support in threatened miscarriage. Maturitas 65(Suppl 1):S43\u2013S46 Epub 2009 Dec 14.","journal-title":"Maturitas"},{"issue":"Suppl 1","key":"2340_CR47","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.maturitas.2009.11.016","volume":"65","author":"RU Pandian","year":"2009","unstructured":"Pandian RU (2009) Dydrogesterone in threatened miscarriage: a Malaysian experience. Maturitas 65(Suppl 1):S47\u2013S50 Epub 2009 Dec 14","journal-title":"Maturitas"},{"issue":"5","key":"2340_CR48","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1053\/beog.2000.0123","volume":"14","author":"L Regan","year":"2000","unstructured":"Regan L, Rai R (2000) Epidemiology and the medical causes of miscarriage. Baillieres Best Pract Res Clin Obstet Gynaecol 14(5):839","journal-title":"Baillieres Best Pract Res Clin Obstet Gynaecol"},{"issue":"7","key":"2340_CR49","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/oxfordjournals.humrep.a137782","volume":"7","author":"J Balasch","year":"1992","unstructured":"Balasch J, F\u00e1bregues F, Creus M, Vanrell JA (1992) The usefulness of endometrial biopsy for luteal phase evaluation in infertility. Hum Reprod 7(7):973","journal-title":"Hum Reprod"},{"issue":"4","key":"2340_CR50","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0015-0282(16)60603-9","volume":"51","author":"OK Davis","year":"1989","unstructured":"Davis OK, Berkeley AS, Naus GJ, Cholst IN, Freedman KS (1989) The incidence of luteal phase defect in normal, fertile women, determined by serial endometrial biopsies. Fertil Steril 51(4):582","journal-title":"Fertil Steril"},{"issue":"5","key":"2340_CR51","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/S0015-0282(97)00328-2","volume":"68","author":"M Ogasawara","year":"1997","unstructured":"Ogasawara M, Kajiura S, Katano K, Aoyama T, Aoki K (1997) Are serum progesterone levels predictive of recurrent miscarriage in future pregnancies? Fertil Steril 68(5):806\u2013809","journal-title":"Fertil Steril"},{"key":"2340_CR52","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0015-0282(97)80080-5","volume":"67","author":"F Ubaldi","year":"1997","unstructured":"Ubaldi F, Bourgain C, Tournaye H, Smitz J, Van Steirteghem A, Devroey P (1997) Endometrial evaluation by aspiration biopsy on the day of oocyte retrieval in the embryo transfer cycles in patients with serum progesterone rise during the follicular phase. Fertil Steril 67:521\u2013526","journal-title":"Fertil Steril"},{"issue":"Suppl","key":"2340_CR53","first-page":"101","volume":"55","author":"NS Macklon","year":"2000","unstructured":"Macklon NS, Fauser BC (2000) Impact of ovarian hyperstimulation on the luteal phase. J Reprod Fertil 55(Suppl):101\u2013108","journal-title":"J Reprod Fertil"},{"key":"2340_CR54","first-page":"1185","volume-title":"Berek & Novak\u2019s Gynecology","author":"RO Burney","year":"2006","unstructured":"Burney RO, Schust DJ, Yao MWM (2006) Infertility. In: Berek JS (ed) Berek & Novak\u2019s Gynecology. Lippincott Williams & Wilkins, Philadelphia, pp 1185\u20131275"},{"issue":"6","key":"2340_CR55","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/humupd\/dmm021","volume":"13","author":"HM Fatemi","year":"2007","unstructured":"Fatemi HM, Popovic-Todorovic B, Papanikolaou E, Donoso P, Devroey P (2007) An update of luteal phase support in stimulated IVF cycles. Hum Reprod Update 13(6):581\u2013590 Epub 2007 Jul 11","journal-title":"Hum Reprod Update"},{"key":"2340_CR56","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jsbmb.2005.08.012","volume":"97","author":"BN Chakravarty","year":"2005","unstructured":"Chakravarty BN, Shirazee HH, Dam P, Goswami SK, Chatterjee R, Ghosh S (2005) Oral dydrogesterone versus intravaginal micronised progesterone as luteal phase support in assisted reproductive technology (ART) cycles: results of a randomised study. J Steroid Biochem Mol Biol 97:416\u2013420","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"10","key":"2340_CR57","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1093\/humrep\/del173","volume":"21","author":"J Tesarik","year":"2006","unstructured":"Tesarik J, Hazout A, Mendoza-Tesarik R, Mendoza N, Mendoza C (2006) Beneficial effect of luteal-phase GnRH agonist administration on embryo implantation after ICSI in both GnRH agonist- and antagonist-treated ovarian stimulation cycles. Hum Reprod 21(10):2572\u20132579 Epub 2006 Aug 22","journal-title":"Hum Reprod"},{"issue":"10","key":"2340_CR58","first-page":"009154","volume":"5","author":"M Linden van der","year":"2011","unstructured":"van der Linden M, Buckingham K, Farquhar C, Kremer JA, Metwally M (2011) Luteal phase support for assisted reproduction cycles. Cochrane Database Syst Rev 5(10):009154","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"2340_CR59","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.fertnstert.2011.11.018","volume":"97","author":"KM Silverberg","year":"2012","unstructured":"Silverberg KM, Vaughn TC, Hansard LJ, Burger NZ, Minter T (2012) Vaginal (Crinone 8\u00a0%) gel vs. intramuscular progesterone in oil for luteal phase support in in vitro fertilization: a large prospective trial. Fertil Steril 97(2):344\u2013348 Epub 2011 Dec 19","journal-title":"Fertil Steril"},{"issue":"5","key":"2340_CR60","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1093\/humrep\/der012","volume":"26","author":"D Kyrou","year":"2011","unstructured":"Kyrou D, Fatemi HM, Zepiridis L, Riva A, Papanikolaou EG, Tarlatzis BC et al (2011) Does cessation of progesterone supplementation during early pregnancy in patients treated with recFSH\/GnRH antagonist affect ongoing pregnancy rates? A randomized controlled trial. Hum Reprod 26(5):1020","journal-title":"Hum Reprod"},{"issue":"4","key":"2340_CR61","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/humrep\/den012","volume":"23","author":"MA Aboulghar","year":"2008","unstructured":"Aboulghar MA, Amin YM, Al-Inany HG, Aboulghar MM, Mourad LM, Serour GI, Mansour RT (2008) Prospective randomized study comparing luteal phase support for ICSI patients up to the first ultrasound compared with an additional three weeks. Hum Reprod 23(4):857","journal-title":"Hum Reprod"},{"issue":"6","key":"2340_CR62","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1093\/humupd\/4.6.856","volume":"4","author":"P Devroey","year":"1998","unstructured":"Devroey P, Pados G (1998) Preparation of endometrium for egg donation. Hum Reprod Update. 4(6):856\u2013861","journal-title":"Hum Reprod Update."},{"issue":"9","key":"2340_CR63","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1093\/humrep\/17.9.2287","volume":"17","author":"EA Pritts","year":"2002","unstructured":"Pritts EA, Atwood AK (2002) Luteal phase support in infertility treatment: a meta-analysis of the randomized trials. Hum Reprod 17(9):2287","journal-title":"Hum Reprod"},{"issue":"5","key":"2340_CR64","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/oxfordjournals.humrep.a137138","volume":"5","author":"C Bourgain","year":"1990","unstructured":"Bourgain C, Devroey P, Van Waesberghe L, Smitz J, Van Steirteghem AC (1990) Effects of natural progesterone on the morphology of the endometrium in patients with primary ovarian failure. Hum Reprod 5(5):537","journal-title":"Hum Reprod"},{"issue":"3","key":"2340_CR65","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0029-7844(99)00542-6","volume":"95","author":"E Cicinelli","year":"2000","unstructured":"Cicinelli E, de Ziegler D, Bulletti C, Matteo MG, Schonauer LM, Galantino P (2000) Direct transport of progesterone from vagina to uterus. Obstet Gynecol 95(3):403","journal-title":"Obstet Gynecol"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-012-2340-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00404-012-2340-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-012-2340-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T13:56:32Z","timestamp":1559051792000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00404-012-2340-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,28]]},"references-count":65,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["2340"],"URL":"https:\/\/doi.org\/10.1007\/s00404-012-2340-4","relation":{},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"value":"0932-0067","type":"print"},{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,28]]}}}